Equity Analysis /
United States of America

US : InflaRx N.V. - IFRX | Upgrade to Strong Buy: PG Data Raise Conviction in IFX-1 Pharmacology Ahead of Ph2 ANCA Data

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    27 October 2021
    Published by